Michael Edward Griffith Boursnell

Title: Michael Edward Griffith Boursnell: Innovator in Viral Vaccines

Introduction

Michael Edward Griffith Boursnell is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of viral vaccines, holding a total of 3 patents. His work focuses on developing mutant viruses that can be used for prophylaxis or therapy against infectious diseases.

Latest Patents

Boursnell's latest patents include innovative approaches to viral vaccines. One of his patents describes a mutant virus that has a defective genome in a gene essential for producing infectious virus. This mutant virus, such as a herpesvirus, is capable of protecting a susceptible species immunized with it against infection by the corresponding wild-type virus. Additionally, the mutant virus can act as a vector for an immunogenic protein derived from a pathogen, encoded by foreign DNA incorporated into the virus. The production of this mutant virus can occur in a recombinant host cell that expresses a gene complementing the defect. The genetic defect allows for the expression of some viral genes in the infected host, which can provoke a cell-mediated immune response.

Career Highlights

Throughout his career, Boursnell has worked with various organizations, including Xenova Research Limited. His innovative research has contributed to advancements in vaccine development and has the potential to impact public health significantly.

Collaborations

Boursnell has collaborated with notable individuals in his field, including Stephen Charles Inglis and Anthony Charles Minson. These collaborations have likely enhanced the scope and impact of his research.

Conclusion

Michael Edward Griffith Boursnell is a distinguished inventor whose work in viral vaccines showcases his commitment to advancing medical science. His innovative patents and collaborations reflect his significant contributions to the field.